Leerink Partners reiterated a Market Perform rating and $166.00 price target on United Therapeutics Corp. (NASDAQ: UTHR) following the company's ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Cowen Remains Bullish on United Therapeutics (UTHR) as Orenitram Continues to Grow October 27, 2015 4:01 PM United Therapeutics (UTHR) Tops Q3 EPS by 120cOctober 27, 2015 6:24 AM United Therapeutics Corporation Reports Third Quarter 2015 Financial ResultsOctober 27, 2015 6:00 AM Trading Radar for 10/26: Apple (AAPL), Twitter (TWTR), Alibaba (BABA), Comcast (CMCSA), Pfizer (PFE) ReportOctober 26, 2015 2:16 PM